These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32375173)

  • 1. The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status.
    Duarte C; Santos E; da Silva JAP; Kristianslund EK; Kvien TK; Dougados M; de Wit M; Gossec L; Heiberg T
    Rheumatology (Oxford); 2020 Nov; 59(11):3458-3467. PubMed ID: 32375173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Experienced Symptom State in rheumatoid arthritis: sensitivity to change in disease activity and impact.
    Duarte C; Kvien TK; Sexton J; Santos E; de Wit M; Gossec L; da Silva JAP
    Rheumatology (Oxford); 2022 Dec; 62(1):98-107. PubMed ID: 35482485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
    Melikoglu MA; Ataman S; Bodur H; Cay HF; Capkin E; Akgul O; Cevik R; Gogus F; Kamanli A; Yurdakul FG; Gurer G; Yagci I; Rezvani A; Duruoz MT; Sunar I
    Rheumatol Int; 2021 Nov; 41(11):1971-1978. PubMed ID: 34559275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population.
    Medeiros MM; de Oliveira BM; de Cerqueira JV; Quixadá RT; de Oliveira ÍM
    Rev Bras Reumatol; 2015; 55(6):477-84. PubMed ID: 25772662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.
    Salaffi F; Di Carlo M; Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Simić Pašalić K; Balčune I; Ferraz-Amaro I; Tlustochowicz M; Butrimienė I; Punceviciene E; Toroptsova N; Grazio S; Morović-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Cutolo M
    Joint Bone Spine; 2018 May; 85(3):317-322. PubMed ID: 28549945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis.
    Heiberg T; Kvien TK; Mowinckel P; Aletaha D; Smolen JS; Hagen KB
    Ann Rheum Dis; 2008 Jul; 67(7):967-71. PubMed ID: 17965118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
    Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
    Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).
    Salaffi F; Cimmino MA; Leardini G; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2009; 27(4):552-9. PubMed ID: 19772784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
    Rintelen B; Sautner J; Haindl PM; Andel I; Maktari A; Leeb BF
    Scand J Rheumatol; 2009; 38(5):336-41. PubMed ID: 19585379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
    Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
    Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.
    Schoels M; Alasti F; Smolen JS; Aletaha D
    Arthritis Res Ther; 2017 Jul; 19(1):155. PubMed ID: 28676129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of CDAI and SDAI indices in comparison to DAS-28 index in Moroccan patients with rheumatoid arthritis.
    Slama IB; Allali F; Lakhdar T; El Kabbaj S; Medrare L; Ngeuleu A; Rkain H; Hajjaj-Hassouni N
    BMC Musculoskelet Disord; 2015 Sep; 16():268. PubMed ID: 26420567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
    Haugeberg G; Hansen IJ; Soldal DM; Sokka T
    Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of indices of activity evaluation in rheumatoid arthritis.
    Hamdi W; Néji O; Ghannouchi MM; Kaffel D; Kchir MM
    Ann Phys Rehabil Med; 2011 Oct; 54(7):421-8. PubMed ID: 21996547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reexamination of the assessment criteria for rheumatoid arthritis disease activity based on comparison of the Disease Activity Score 28 with other simpler assessment methods.
    Fujiwara M; Kita Y
    Mod Rheumatol; 2013 Mar; 23(2):260-8. PubMed ID: 22546955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
    Lee SW; Kim SY; Chang SH
    BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.